Show Menu
Cheatography

MKULTRA Timeline Cheat Sheet (DRAFT) by

A Timeline of MKULTRA

This is a draft cheat sheet. It is a work in progress and is not finished yet.

1940s: Origins & Early CIA Interest

1945-47
Context: The CIA (estab­lished in 1947) and its predec­essors were concerned about potential Soviet and Chinese brainw­ashing methods after WWII.
 
OSS Experi­ments Influence: MKULTRA drew inspir­ation from Office of Strategic Services (OSS) experi­ments on interr­ogation techniques and mind control during WWII.
 
Early research included studies on hypnosis, truth serums (e.g., sodium pentot­hal), and sensory depriv­ation.
1947
Establ­ishment of CIA: The CIA is officially formed, inheriting OSS interest in mind control, interr­oga­tion, and behavior modifi­cation.
 
Initial studies focus on psycho­tropic drugs and interr­ogation techni­ques, with informal cooper­ation from univer­sities and hospitals.

1950–52: Concep­tua­lis­ation and Early Experi­ments

1950
CIA initiates interest in "­beh­avioral engine­eri­ng" and chemical interr­oga­tion.
 
Dr. Sidney Gottlieb joins as a chemist and becomes key in planning covert programs.
1951
Experi­ments on LSD (lysergic acid diethy­lamide) begin, invest­igating its potential for mind control.
 
Early tests conducted on CIA employees and willing volunteers at labs.
1952
CIA acquires knowledge of Soviet and Chinese “brain­was­hing” techniques from POW reports during the Korean War.
 
Focus expands from interr­ogation enhanc­ement to potential human control.

1953: Formal­isation of MKULTRA

April 1953
CIA Director Allen Dulles officially authorizes MKULTRA via a top-secret memora­ndum.
 
Program purpose: “Research on methods of influe­ncing and contro­lling human behavior.”
 
Sidney Gottlieb appointed to oversee the program; he organizes it into multiple subpro­jects.
1953-55
MKULTRA expands to include subpro­jects at over 80 instit­utions, including univer­sities, hospitals, prisons, and private companies.
 
Methods tested include: LSD and other halluc­ino­gens. Hypnosis and subliminal messaging. Sensory depriv­ation and isolation. Electr­oco­nvu­lsive therapy (ECT) and other psychi­atric interv­ent­ions.
 

Mid-1950s: Expansion and Secret Testing

1954
MKULTRA begins covert experi­ments on unwitting subjects, including civilians.
 
Tests often conducted in hospitals, prisons, and CIA safe houses.
 
Some experi­ments are linked to CIA front organi­zat­ions, such as Society for the Invest­igation of Human Ecology.
1955-57
Focus on LSD: Gottlieb believes LSD could be used for interr­oga­tion, manipu­lation, and even assass­ina­tion.
 
CIA experi­ments attempt to assess the drug’s ability to cause compli­ance, memory loss, or psycho­logical breakdown.
1956
Subproject 54: LSD testing on prisoners in Kentucky; many report long-term psycho­logical effects.
 
Early concern about ethics emerges intern­ally, but research continues due to Cold War urgency.

Late 1950s: Extreme Methods and Secret Expansion

1957-59
MKULTRA experi­ments include: Electr­oshock therapy on unwitting subjects. Radioa­ctive tracers to study drug absorption and behavior modifi­cation (precursor to Project MKOFTEN). Hypnosis and person­ality disruption studies.
 
Safe houses and CIA front labs increa­singly used for covert testing on civilians.
1958
LSD is secretly given to unsusp­ecting CIA operatives and public volunteers in field tests.
 
Early attempts to test mass-use applic­ations, including surrep­titious dosing in social settings, are docume­nted.

1960s: Height of Experi­men­tation

1960-63
MKULTRA grows more secretive; subpro­jects diversify: Subpro­jects test biological agents, halluc­ino­gens, and new psycho­tropic drugs. Some experi­ments attempt behavior modifi­cation via hypnosis combined with drugs.
 
Key event: Dr. Frank Olson, a CIA bioche­mist, is dosed with LSD unknow­ingly, resulting in psycho­logical distress. He dies in 1953 (offic­ially ruled a suicide), later becoming a major scandal.
1961-64
CIA explores mind control for espionage purposes, including “progr­ammable agents” and covert assass­ination techni­ques.
 
Experi­men­tation on vulnerable popula­tions such as mental patients, prisoners, and drug users increases.
 
Early indica­tions of ethical and legal issues arise intern­ally.
1962
MKULTRA subpro­jects reach univer­sities, research hospitals, and psychi­atric clinics across the US and Canada (e.g., Montreal Experi­ments at McGill Univer­sity).
1963
Project absorbs Project Artichoke (CIA mind control and interr­ogation initiative from 1951–1­953), consol­idating efforts in LSD and hypnosis research.
1964-65
LSD and chemical experi­ments on unwitting civilians continue.
 
CIA begins assessing long-term effects and the limits of mind control techni­ques.
 
Internal memos express concern about lack of oversight and the risk of public exposure.
 

Late 1960s: Scaling Down and Cover-up

1965-67
Reports of adverse effects (psychotic breaks, deaths, extreme psycho­logical trauma) accumu­late.
 
Increasing public scrutiny of government research programs prompts internal discus­sions about termin­ation.
 
Experi­ments on civilian popula­tions largely phased out, though classified studies on operatives continue.
1967
Director Richard Helms orders destru­ction of most MKULTRA files to prevent discovery during future congre­ssional invest­iga­tions.
 
Remaining subpro­jects largely reclas­sified under other CIA programs.

1970s: Exposure

1973
CIA Director Richard Helms orders all MKULTRA files destroyed following growing scrutiny.
 
Only ~20,000 documents survive, mainly in financial and admini­str­ative records.
1975
Church Committee Invest­iga­tion: The U.S. Senate invest­igates CIA miscon­duct, including MKULTRA, human experi­men­tation, and assass­ination plots.
 
Senate finds widespread ethical violat­ions, secret dosing of civilians, and government cover-ups.
1977
Freedom of Inform­ation Act (FOIA) requests lead to additional MKULTRA documents being released.
 
Public learns of unwitting human experi­men­tation, including cases like Frank Olson and various prison experi­ments.
1979
A Presid­ential Commission under Gerald Ford examines CIA abuses and MKULTRA.
 
Recomm­end­ations made for stricter oversight of classified human experi­men­tation.

Legacy and Aftermath

1980s–­2000s
Further FOIA releases provide insight into the scale of MKULTRA experi­ments.
 
Survivors and families, notably Frank Olson’s, pursue legal action against the CIA.
 
Academic research evaluates MKULTRA in the context of ethics, Cold War paranoia, and psycho­logical experi­men­tation.
Present
MKULTRA is widely cited as a cautionary tale in government overreach, bioethics, and covert experi­men­tation.
 
Many of its methods, while secretive, contri­buted indirectly to modern psycho­pha­rma­cology and behavioral research.